Pimvanserin Does Not Adversely Impact Cognitive Outcomes in Neurodegenerative Disease
Study authors determined the impact of pimavanserin on cognitive function in patients with neuropsychiatric manifestations of neurodegenerative disease.
Neurocognitive
Pimavanserin Effective for Depression in Parkinson Disease, Major Depressive Disorder
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Poor Dental Health May Increase Risk for Incident Dementia, MCI
Individuals with severe periodontal disease or edentulism have an increased risk for incident dementia.
Vaccination Linked to Reduced Alzheimer Disease Risk
At AAIC 2020, 2 presentations separately discussed observing a reduced risk of AD in patients who received the influenza and pneumonia vaccines.
Frontal Lobe Cognitive Dysfunction Symptom Reduction Associated With Rotigotine Therapy
Researchers conducted a randomized clinical trial to assess whether 24 weeks of treatment with rotigotine can modify cognitive functions in patients with mild to moderate Alzheimer disease.
CV Risk Factors Linked to Faster Cognitive Decline in Midlife
Cardiovascular risk factors are associated with accelerated cognitive decline in midlife.
Reduced Circadian Rhythmicity Tied to Increase in Parkinson Disease
Reduced circadian rhythmicity is associated with an increased risk for incident Parkinson disease.
Novel Therapy for Alzheimer Disease Agitation Gets Breakthrough Designation
The FDA has granted Breakthrough Therapy designation to AXS-05 (Axsome Therapeutics) for the treatment of Alzheimer disease (AD) agitation.
The Role of Precision Medicine in Parkinson Disease
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
Unpacking Parkinson Disease Psychosis: Diagnosis and Treatment
Severe neuropsychiatric dysfunction, including psychosis and dementia, is associated with more advanced Parkinson disease.
- Loading...
Loading...
Next post in Parkinson Disease
Loading... 
Loading...